Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma

  • Robert J. Vanner
  • , Marc Remke
  • , Marco Gallo
  • , Hayden J. Selvadurai
  • , Fiona Coutinho
  • , Lilian Lee
  • , Michelle Kushida
  • , Renee Head
  • , Sorana Morrissy
  • , Xueming Zhu
  • , Tzvi Aviv
  • , Veronique Voisin
  • , Ian D. Clarke
  • , Yisu Li
  • , Andrew J. Mungall
  • , Richard A. Moore
  • , Yussanne Ma
  • , Steven J.M. Jones
  • , Marco A. Marra
  • , David Malkin
  • Paul A. Northcott, Marcel Kool, Stefan M. Pfister, Gary Bader, Konrad Hochedlinger, Andrey Korshunov, Michael D. Taylor, Peter B. Dirks

Research output: Contribution to journalArticlepeer-review

249 Citations (Scopus)

Abstract

Functional heterogeneity within tumors presents a significant therapeutic challenge. Here we show that quiescent, therapy-resistant Sox2+ cells propagate sonic hedgehog subgroup medulloblastoma by a mechanism that mirrors a neurogenic program. Rare Sox2+ cells produce rapidly cycling doublecortin+ progenitors that, together with their postmitotic progeny expressing NeuN, comprise tumor bulk. Sox2+ cells are enriched following anti-mitotic chemotherapy and Smoothened inhibition, creating a reservoir for tumor regrowth. Lineage traces from Sox2+ cells increase following treatment, suggesting that this population is responsible for relapse. Targeting Sox2+ cells with the antineoplastic mithramycin abrogated tumor growth. Addressing functional heterogeneity and eliminating Sox2+ cells presents a promising therapeutic paradigm for treatment of sonic hedgehog subgroup medulloblastoma.

Original languageEnglish
Pages (from-to)33-47
Number of pages15
JournalCancer Cell
Volume26
Issue number1
DOIs
Publication statusPublished - 14 Jul 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma'. Together they form a unique fingerprint.

Cite this